Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype (NADMet)

Still recruiting volunteers….

We are looking for participants for our clinical study looking at the metabolic benefits of increasing NAD (Nicotinamide Adenine Dinucleotide) biosynthesis in skeletal muscle, via Nicotinamide Riboside supplementation,  in human ageing, as a target tissue for susceptibility to age-related disease, frailty and incapacity.

If you are male and aged 70-80 years of age and have none of the following…

  • Significant past medical history including diabetes mellitus, heart disease, previous stroke, lung disease requiring treatment, epilepsy
  • High blood pressure (Bp 160/100mmHg)
  • Blood thinning drugs like Warfarin, Rivaroxaban, Dabigatran or Clopidogrel therapy which will increase the risk of bruising following a muscle biopsy,

…then please contact Dr Yasir Elhassan on either (0121) 415 8705 or Y.MohamedElhassan@bham.ac.uk

Read the Participant Information Sheet

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s